Extravasation of yttrium-90 ibritumomab tiuxetan: a case study.

Author: SiebeneckBettina M

Paper Details 
Original Abstract of the Article :
Ibritumomab tiuxetan is a radiolabled monoclonal antibody that targets B-cell non-Hodgkin lymphoma tumor cells. Yttrium-90 (Y-90), the radioisotope used to deliver the therapy, may act as a vesicant, potentially causing severe tissue damage if extravasation occurs. Particularly important to nurses i...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1188/08.CJON.275-278

データ提供:米国国立医学図書館(NLM)

Extravasation of Yttrium-90 Ibritumomab Tiuxetan: A Case Study in the Desert of Medical Complications

The desert of medical complications is a vast and unforgiving landscape, where unexpected challenges can arise during even the most routine procedures. This case study delves into the intricacies of extravasation, a potentially serious complication that can occur during the administration of certain medications, specifically focusing on yttrium-90 ibritumomab tiuxetan, a radiolabeled monoclonal antibody used to treat B-cell non-Hodgkin lymphoma. The authors meticulously document the progression of extravasation in a patient and outline the steps taken to manage this challenging situation.

Navigating the Desert of Extravasation

This case study provides a valuable lesson in the complexities of extravasation, highlighting the importance of vigilance and prompt action in managing this potentially serious complication. The authors emphasize the need for meticulous monitoring of the infusion site, even in the absence of immediate signs or symptoms, as delayed reactions can occur weeks or months after the initial administration. This study also underscores the importance of comprehensive education and training for healthcare professionals involved in the administration of potentially vesicant medications.

A Cautionary Tale in the Desert

This case study serves as a stark reminder of the potential for unexpected complications in the realm of medicine. While extravasation may not always occur, it is crucial to remain vigilant and prepared to respond promptly and effectively. This research underscores the importance of careful patient selection, thorough administration protocols, and continuous monitoring to minimize the risk of this challenging complication. As we navigate the desert of medical practice, it's essential to embrace a proactive approach and prioritize patient safety.

Dr. Camel's Conclusion

This case study offers a cautionary tale in the desert of medical complications, highlighting the importance of vigilance and preparedness in managing extravasation. By embracing a proactive approach and prioritizing patient safety, we can effectively navigate the complexities of medical practice and mitigate the risks associated with potential complications.

Date :
  1. Date Completed 2008-06-19
  2. Date Revised 2016-11-24
Further Info :

Pubmed ID

18390463

DOI: Digital Object Identifier

10.1188/08.CJON.275-278

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.